Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 6/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.35 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8103924 | 0.91 | — | — | |
| SCHEMBL8105911 | 0.89 | KMT2A (0.35) | ALDH1A1 | |
| SCHEMBL8098702 | 0.89 | ALDH1A1 (0.38) | CACNA1HALDH1A1 | |
| SCHEMBL8103628 | 0.86 | SLC6A4 (0.37) | CYP2D6ALDH1A1 | |
| SCHEMBL8105610 | 0.86 | CYP1A2 (0.41) | CYP2D6USP2ALDH1A1 | |
| SCHEMBL8099316 | 0.85 | TACR1 (0.33) | — | |
| SCHEMBL8105285 | 0.84 | MAPT (0.37) | ALDH1A1 | |
| SCHEMBL8097540 | 0.84 | POLB (0.36) | USP2ALDH1A1 | |
| SCHEMBL8099351 | 0.83 | RECQL (0.38) | CYP2D6USP2ALDH1A1 | |
| SCHEMBL8097595 | 0.83 | KMT2A (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0672038-B1 | HERBICIDES | ZENECA LTD (GB) | 2000-01-19 | — | — | EP | disclosed |
| US-5856273-A | CONTROLLING WEEDS | ZENECA LIMITED (GB) | 1999-01-05 | — | — | US | disclosed |
| EP-0672038-A1 | HERBICIDES | ZENECA LIMITED (GB) | 1995-09-20 | — | — | EP | disclosed |
| WO-1994013652-A1 | HERBICIDES | ZENECA LIMITED (GB) | 1994-06-23 | — | — | WO | disclosed |